PioLigOn

PioLigOn is a biotechnology startup, established in 2020, headquartered in Poland. The company's slogan, "Platform for designing peptide drugs," underscores its commitment to revolutionizing drug discovery. Their flagship product, VPDesigner42™, offers a cutting-edge approach to drug development, harnessing the latest advancements in computational de novo peptide design and unnatural peptide synthesis. The startup received a significant boost with a $270.00K grant investment on 16 April 2021. This strategic funding is poised to propel PioLigOn's innovative solutions to the forefront of the biotechnology industry. As a venture capitalist, this presents a compelling opportunity to engage with a groundbreaking company that is at the vanguard of peptide drug design and development.